Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-119593
Filing Date
2024-10-31
Accepted
2024-10-31 16:42:24
Documents
1
Period of Report
2024-10-23

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 15024
  Complete submission text file 0000950170-24-119593.txt   16699
Mailing Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60
Business Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60 353 1 6699 020
AMARIN CORP PLC\UK (Issuer) CIK: 0000897448 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 440 RT 22 BRIDGEWATER NJ 08807
Business Address
Fishman Peter L. (Reporting) CIK: 0002042862 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-21392 | Film No.: 241415814